Nilufer Alpay Kanitez
Overview
Explore the profile of Nilufer Alpay Kanitez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaymaz-Tahra S, Bayindir O, Ince B, Ozdemir Isik O, Kutu M, Karakas O, et al.
Semin Arthritis Rheum
. 2024 Apr;
66:152446.
PMID: 38669786
Background: Immunosuppressive (IS) agents are recommended for the first-line treatment of patients with active Takayasu's arteritis (TAK) together with glucocorticoids (GCs). However, there is limited data comparing the efficacy and...
2.
Ersozlu E, Ekici M, Coskun B, Badak S, Bilgin E, Kalyoncu U, et al.
Arch Rheumatol
. 2023 Dec;
38(3):347-357.
PMID: 38046251
Objectives: This study aimed to evaluate the hepatitis B (HBV) and C (HCV) frequency and clinical characteristics among patients with rheumatoid arthritis (RA) or spondyloarthritis (SpA) who receive biological treatments....
3.
Yagiz B, Lermi N, Coskun B, Dalkilic E, Kiraz S, Erden A, et al.
Rheumatology (Oxford)
. 2023 Jun;
62(12):3962-3967.
PMID: 37354493
Objectives: The objectives of this study were to assess the clinical characteristics, predictive factors, and practical algorithms of paradoxical reactions (PRs), specifically paradoxical psoriasis (PP). Methods: The TReasure database is...
4.
Kanitez N, Kiraz S, Dalkilic E, Kimyon G, Mercan R, Karadag O, et al.
Eur J Rheumatol
. 2023 Jan;
9(4):206-211.
PMID: 36650959
Objective: The coronavirus disease 2019 pandemic has been resulting in increased hospital occupancy rates. Rheumatic patients cannot still reach to hospitals, or they hesitate about going to a hospital even...
5.
Somay K, Eren I, Kapmaz M, Caglayan B, Durur Karakaya A, Kanitez N
Eur J Rheumatol
. 2022 Dec;
9(4):227-228.
PMID: 36476667
No abstract available.
6.
Kalyoncu U, Kasifoglu T, Omma A, Bes C, Cinar M, Emmungil H, et al.
Joint Bone Spine
. 2022 Nov;
90(1):105499.
PMID: 36423781
Objectives: Adult-onset Still's disease (AOSD) is a multi-systemic, autoinflammatory disorder. Several activity scores have been proposed but none of them have been adopted universally. Our aim was to create a...
7.
Atagunduz P, Kiraz S, Akar S, Kucuksahin O, Erden A, Aksoy A, et al.
Clin Exp Rheumatol
. 2022 Jun;
41(3):620-627.
PMID: 35766019
Objectives: To analyse the clinical and laboratory factors associated with bamboo spine. Methods: Data of patients fulfilling the 2009 ASAS classification criteria for axial spondyloarthritis, registered in the national, multicentre,...
8.
Ilgen U, Karadag O, Emmungil H, Kucuksahin O, Koca S, Erden A, et al.
Rheumatol Int
. 2022 Apr;
42(10):1797-1806.
PMID: 35486197
This study aimed to compare Tuberculin Skin Test (TST) and QuantiFERON®-TB Gold In-Tube (QFT-GIT) test in rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients scheduled for biological and targeted synthetic disease...
9.
Alibaz-Oner F, Kaymaz-Tahra S, Bayindir O, Yazici A, Ince B, Kalkan K, et al.
Semin Arthritis Rheum
. 2021 Oct;
51(6):1224-1229.
PMID: 34706312
Objective: To compare the treatment outcomes of TNF inhibitors and tocilizumab (TCZ) in patients with Takayasu arteritis. Methods: Takayasu arteritis patients who were refractory to conventional immunosuppressive (IS) drugs and...
10.
Yagiz B, Coskun B, Pehlivan Y, Dalkilic E, Kiraz S, Yazisiz V, et al.
Rheumatol Int
. 2021 Jul;
41(11):1915-1924.
PMID: 34226947
We wanted to see how close we could get to our goal of treating rheumatoid arthritis (RA) without the use of glucocorticoids (GCs) in the disease-modifying antirheumatic drugs (DMARDs) era...